The useful synthesis of the main central2,3,6-trisubstituted pyridine skeleton [the protected Fragment A-B-C] of a macrobicyclic antibiotic, cyclothiazomycin, was first accomplished. First, the 2-[2-(2-substituted thiazol-4-yl)]-4,5-dihydrothiazole-4-carboxylate [Fragment A derivative], attached to the 6-substituent of the main pyridine skeleton, was synthesized by two consecutive thiazolations of the protected Ser thioamide derivative with 3-bromopyruvate, and then thiazolination of the C-terminal Ser residue of the sequence. Secondly, an efficient synthesis of the central 2-(2-{2-[( lR)-1-aminoethyl]pyridin-6-yl Ithiazol-4-yl)-4,5-dihydrothiazole-4-carboxylate [Fragment B derivative] was also achieved by thiazolation of the formyl group of the 2-(I-aminoethyl)-6-formylpyridine derivative, and then thiazolination. Thirdly, a convenient synthesis of the protected dehydrotetrapeptide [Fragment C derivative], which is bound to the 2-substituent of the pyridine skeleton, was attained by the usual stepwise elongation of the appropriate a-amino acids and ,
The useful synthesis of the main central2,3,6-trisubstituted pyridine skeleton [the protected Fragment A-B-C] of a macrobicyclic antibiotic, cyclothiazomycin, was first accomplished. First, the 2-[2-(2-substituted thiazol-4-yl)]-4,5-dihydrothiazole-4-carboxylate [Fragment A derivative] , attached to the 6-substituent of the main pyridine skeleton, was synthesized by two consecutive thiazolations of the protected Ser thioamide derivative with 3-bromopyruvate, and then thiazolination of the C-terminal Ser residue of the sequence. Secondly, an efficient synthesis of the central 2-(2-{2-[( lR)-1-aminoethyl]pyridin-6-yl Ithiazol-4-yl)-4,5-dihydrothiazole-4-carboxylate [Fragment B derivative] was also achieved by thiazolation of the formyl group of the 2-(I-aminoethyl)-6-formylpyridine derivative, and then thiazolination. Thirdly, a convenient synthesis of the protected dehydrotetrapeptide [Fragment C derivative] , which is bound to the 2-substituent of the pyridine skeleton, was attained by the usual stepwise elongation of the appropriate a-amino acids and ,B-elimination of a Thr residue of the sequence. Finally, the facile fragment condensation of the three Fragments thus obtained gave the protected Fragment A-B-C derivative via Fragment A-B. Furthermore, the configurational structures of the three Fragments (A, B, and C) were also investigated.
Cyclothiazomycin (1),1 isolated from a culture of Streptomyces NR0516, is a very interesting thiostrepton-type macrobicyclic antibiotic. So far, many structurally similar thiostrepton antibiotics, such as GE 2270 A,2 micrococcins P and P I ,3 have also been isolated from various kinds of strains. However, no total synthesis of any similar antibiotic has yet been reported, except for the recent syntheses of micrococcin P and p(. 4--{) The cyclothiazomycin features a very unique structure and interesting bioactivities,I which attracted our attention and prompted us to investigate its total synthesis and structure-bioactivity relationship. The natural product 1 includes a charac- -439-
In connection with the total synthesis of 1, we have already briefly reported a novel synthesis of the protected Fragment A derivative (P)_4 7 by two consecutive thiazolations, and then thiazolination of the protected Ser thioamide derivative with 3-bromopyruvate by the Hantzsch method. s More recently,9 a useful synthesis of the protected Fragment B derivative (P)-5 by successive thiazolination and thiazolation of a 2,3-disubstituted 6-formylpyridine derivative lO with H-Cys-OMe was achived by the Shioiri method. 11 Furthermore, the facile synthesis of the protected Fragment A-B drivative (P)-3 by the coupling of Fragment A with Fragment B, mentioned above, has also been briefly reported. 9 In this paper, we wish to report in detail on versatile synthetic methods for all of the Fragment derivatives [(P) -4, 5, and 6] , the protected Fragment [A-B (P)-3], and Fragment A-B-C derivatives [(P)-2], derived by coupling of (P)-3 with (P)-6. Furthermore, in order to determine which of the two synthetic stereoisomers, 2-(l'R)-and 2-(l'S)-(P)-5, is identical to the configuration of natural 1, the structures of the two isomers were thoroughly examined by comparing the circular dichroism (CD) spectra and the specific rotations ([a] l» with those of an independently prepared structurally similar 2-(1-aminoethyI)pyridine derivative.
Results and Discussion
The novel syntheses of the protected Fragment A, B, and C derivatives and their couplings for the formations of the protected Fragments A-B and A-B-C derivatives were accomplished as follows. In particular, with regard to the synthesis of the Fragment A (P)-4, since the previous synthetic method 7 was found to be slightly difficult, and the overall yield from Ser is very low (2%), an alternative revised method was adopted. First of all, to synthesize the protected 3,4-bithiazolylthiocarbonyl-Ser-OMe derivative 16 as the precursor of (P)-4, the synthesis of the desired thiazolylthiazole sequence 13 by the stepwise thiazolations of thioamides was successfully tried. Initially, the thiazolation of the 3-t-butoxycarbonyl(Boc)-2,2-dimethyloxazolidine-4-thiocarboxamide (7),4 derived from Boc-L-Cys-OH and acetone, with ethyl 3-bromopyruvate in the presence of KHC0 3 , and then with trifluoroacetic anhydride (TFAA) and pyridine, proceeded to give 2-substituted thiazole-4-carboxylate derivative 8 by the Hantzsch method. s After ester hydrolysis with 1 M LiOH (l M = 1 mol dm-3), amidation of the formed free carboxylic acid 9 with CICOOEt and then a 28% NH 3 aqueous solution gave the corresponding thiazole-4-carboxamide derivative 10. Similarly to the case of 8, thioamidation with Lawesson's reagent, followed by thiazolation of the formed thiazole-4-thioamide 11 with ethyl 3-bromopyruvate, gave the corresponding 2-substituted 2-(thiaz-01-4-yl)thiazole-4-carboxylate derivative 12. The ester was again hydrolyzed with 1 M LiOH to give the corresponding free acid 13.
Subsequently, the coupling of 13 with H-L-Ser(TBS)-OMe (TBS = t-butyldimethylsilyl) by using DPPA (OPPA = diphenyl phosphorazidate)12 as the condensing agent, followed by thioamidation of the formed peptide derivative 14 with Lawesson's reagent gave 2,4-bithiazole-4-thiocarbonyl-Ser-(TBS)-OMe 15. Deprotection of the TBS group with TBAF (tetrabutylammonium fluoride) was then performed to give the Main Structure ojCyclothiazornycin corresponding thiocarbonyl-Ser-OMe derivative 16, which was treated with triphenylphosphine (Ph 3 P) and diethyl azodicarboxylate (DEAD) by the Mitsunobu reaction l3 to give the expected 2-(2,4'-bithiazo1-4-y1) -4,5-dihydrothiazole-4-carboxylate 17. Finally, deprotection of only the isopropylidene (Isop) group of the 2,2-dimethyloxazolidine ring with a mixture of trifluoroacetic acid (TFA) and CHC1 3 (4:96 v/v) gave the corresponding 2-[2'-( l-amino-2-hydroxyethyl)-2,4'-bithiazol-4-yl]-4,5-dihydrothiazole derivative 18. Subsequent protection of the formed hydroxy group of 18 with t-butyldiphenylsilyl chloride (TPS-Cl) in the presence of imidazole gave the corresponding 2-(0-TPS)ethyl derivative 19 as the protected Fragment A derivative, as shown in Scheme 1. As a result, a convenient synthesis of 19 was achieved by two consecutive thiazolations and thiazolination from 7; the overall yield was found to attain to 19% from Ser. Later, after deprotection of the Boc group of 19 with TFA, without isolation, the obtained amino group free amino-2-(2,4'-bithiazol-4-yl)-4,5-dihydrothiazole derivative (P)-4 was intact utilized to the next coupling with (P)-5.
The structure of 19 was determined by the 1H NMR spectral data and satisfactory elemental analysis. In particular, the appearances of two protons of the thiazole rings as a singlet at 8 8.03 and 8.04 , the methylene protons as a double doublet at 8 3.68 (J = 5.8 and 9.2 Hz) and the methine proton of tqiazoline (4,5-dihydrothiazole) ring as a triplet at 85.32 supported the formation of 19.
On the other hand, to synthesize the Fragment B derivative, as was already reported,9 first, the starting 3-cyano-6-dimethoxymethyl-2-pyridone (20)10 was converted to the corresponding 2-oxo-l ,2-dihydropyridine-3-carboxylic acid 21 by hydrolysis of the cyano group with 6 M KOH. Without the isolation of 21, one-pot esterification with MeOH gave the methyl ester 22, the carbonyl group of which was then triflated with trifluoromethanesulfonic (triflic) anhydride (Tf 2 0) to give the corresponding 2-(trifluoromethylsulfonyloxy)pyridine derivative 23. The 2-TfO group was then treated with ethyl vinyl ether in the presence of Pd(OAc)2 and dppp [l,3-bis(diphenylphosphino) propane] to give the 2-(I-ethoxyvinyl)pyridine derivative 24. Without the purification of 24, the conversion of the ethoxyvinyl group to an acetyl group by using 70% AcOH afforded the corresponding 2-acetyl-3-methoxycarbonyl derivative 25, which was then subjected to reduction.. That is, the simultaneous reductions of both the acetyl and methoxycarbonyl groups with NaB~in the presence of CaCh gave the (RS)-2-( I-hydroxyethy1)-3-(hydroxymethyl)pyridine derivative 26 as a racemate. Subsequently, the formed primary hydroxy group of 26 was protected by TPS-Cl to give the 3-(0-TPS-hydroxymethyl)pyridine derivative 27, and the secondary hydroxy group was mesylated with methanesulfonyl (mesyl) chloride (Ms-Cl) in the presence of Et3N and then azidated with NaN 3 in one-pot to give the corresponding 2-(l-azidoethyl)pyridine derivative 28. The hydrogenolysis of the azido group with 10% Pd-C/H2 gave the 2-(l-aminoethyl)pyridine , derivative 29, the amino group of which was in situ protected with BOC20 (di-t-butyl dicarbonate) to give the expected Secondly, in order to construct the thiazolylthiazoline-4-carboxylate segment to the 6-position of the pyridine ring of 30, in the first place, the 6-dimethoxymethyl group was hydrolyzed. That is, the hydrolysis of the 6-dimethoxymethyl group with 2 M HCI, followed by one-pot thiazolation of the formed 6-formylpyridine derivative 31 with H-L-Cys-OMe and then oxidation with Mn02,Il gave the 2-(pyridin-6-yl)thiazole-4-carboxylate derivative 32. The subsequent ester hydrolysis of 32 with 1 M LiOH gave the free acid 33, without purification, the carboxyl group of which was again esterified with phenacyl bromide (Pac-Br) to give the corresponding Pac ester 34. On the other hand, deprotection of the 3-(O-TPS)hydroxymethyl group by using TBAF was followed by oxidation of the formed 3-(hydroxymethyl)pyridine derivative 35 with Jones' reagent. As a result, unexpectedly, the formed labile 2- [l-(NBoc) aminoethyl]pyridine-3-carboxylic acid was immediately intramolecularly cyclized to give the corresponding y-Iactam derivative 36. Fortunately, it was found that the formation of the y-Iactam ring resulted in the effective protection of the 2 and 3-positions of 36. Consequently, after hydrolysis of the Pac ester with K 2 C0 3 aqueous solution, without isolation, the formed free acid 37 was in situ coupled with H-L-Ser(TBS)-OBut by the DPPA method to give the 2-(pyridin-6-yl)thiazoloyl-Ser-OBu l derivative 38 as a diastereomeric mixture. Furthermore, the y.lactam ring was easily clevaged with 1 M LiOH to give the corresponding 3-carboxyl-pyridine derivative 39, which was utilized in the next reaction without isolation.
Later, to differentiate the carboxy (C-) terminal t-butyl ester from another ester, the carboxyl group of 39 was esterified with benzyl bromide (Bn-Br) to give the corresponding 3-benzyl ester derivative 40. Similarly to the case of 15, the thioamidation of 40 with Lawesson's reagent gave the expected thiocarbonyl-Ser(TBS) derivative 41. Although compound 41 was obtained as a diastereomeric mixture, the separation was tried very successfully. That is, after the deprotection of the TBS group with 2 M HCI, the product was chromatographed intact on a silica-gel column using a mixture of CHCl 3 and acetone (50: 1 v/v) to give the corresponding 2-[(lR)-and (IS)-Iaminoethyl]pyridine derivatives 42 from the last eluate and 43 from the first eluate, respectively.
Lastly, one of the diastereomers 42 was thiazolinated with Mitsunobu reagent 13 to give only the corresponding 2-[2-(pyridin-6-yl)thiazol-4-yl]-4,5-dihydrothiazole derivative 44. On the other hand, in the case of another diastereomer 43, interestingly, although similar thiazolination proceeded, it was found that a mixture of the thiazolylthiazoline derivative 46 and thiazolylithiazole derivative 47 was obtained in 67% yield in a 1: 2.5 ratio. The obtained mixture could be readily separated by the chromatogram method on a silica-gel column using a mixture of hexane and EtOAc (2: I v/v). Subsequently, oxidation of the thiazoline ring of 44 with Mn02 in toluene gave the corresponding bithiazole derivatives 45, similar to 47, as shown in Scheme 3. As a result, the physical (IR and IH NMR) and chemical constants (mp and elemental analysis) of 45 and 47 were found to be completely identical, but only the sign of the specific rotations were reversed. These facts clearly indicate that compounds 44 and 46 as well as 42 and 43 are diastereomers; further, 45 and 47 are enantiomers to each other. Naturally, it is neccessary to examine which of the two configurational structures of 44 and 46 is identical with that of the natural product (1). Accordingly, in order to determine the configuration of the 2-(l-aminoethyl) moiety of the synthetic 44 and 46, both (R)-and (S)-configurational 2-[I-(N-Boc)aminoethyl]pyridines (51) were independently synthesized, and their CD spectra were compared with those of 44 and 46. That is, the well-known asymmetric reduction of 2-acetylpyridine (48) with Baker's Yeast afforded the authentic (S)-2-(I-hydroxyethyl)pyridine 49,14 which was further converted to (R)-51 via (R)-2-(l-azidoethyl)pyridine 50. The specific rotation value of 49 thus obtained was [a] fi6 -55.5°(c 1. 6, EtOH) Ilit. 14 [a] (lH), and the thiazoline ring protons at 83.63 as a doublet (2H, 1 = 9.2 Hz) and at 85.22 as a triplet (lH, 1 = 9.2 Hz) definitely support the Fragment B skeleton structure. Therefore, it could be completely determined that the absolute structure of 44 was the (l'R,4S)-configuration and identical with that of the natural 1. As a result, the compound (P)-5 (44) was found to be first synthesized.
In addition, to synthesize the protected Fragment C derivative (P)-6, the condensation of N-Boc-N,O-Isop-L-Thr-OH (52) with H-Gly-OMe by the usual DeC and N-hydroxysuccinimide (HOSu) method gave the corresponding dipeptide methyl ester 53, the methyl ester of which was hydrolyzed with 1 M LiOH to give the free carboxylic acid 54. Similarly, compound 54 was elongated by coupling with H-L-Thr(TBS)-OMe to give the protected tripeptide methyl ester 55, the TBS group of which was then deprotected with TBAF to give the protected L-Thr-Gly-L-Thr-OMe derivative 56. Subsequently, to synthesize the expected~3-dehydrotripeptide,15 the t3-elimination of 56 with successive Ms-CI in the presence of Et 3 N and with DBU (l,8-diazabicyclo[5.4 .0]undec-7-ene) was performed to give the protected .:
, by a previously reported method. 16 After ester hydrolysis with 1 M LiOH, the obtained free acid 58 was further elongated with H-L-Pro-OMe by the DCC method to give~3-dehydrotetrapep tide methyl ester 59, the methyl ester of which was finally hydrolyzed to give the corresponding hydrolyzate derivative (P)-6 as the protected Fragment C, as shown in Scheme 5. The geometry of the~Abu residue was readily determined to be the (Z)-configurational structure by a comparison with the extensive IH NMR data of the authentic samples previously reported by us.
Finally, the hydrolysis of the t-butyl ester of (l'R,4S)-(P)-5 with a mixture of TFA and CHCh (3:2 v/v), accompanying deprotection of the Boc group, gave the corresponding free intermediate of both the amino and carb<;>xyl groups. The amino group of the yielded intermediate was protected intact again with BOC20 to give the corresponding N-Boc-4,5-dihydrothiazole-4-carboxylic acid derivative 60. Without isolating 60, one-pot coupling with (P)-4 gave the protected Fragment A-B derivative (P)-3, by the BOP method. 18 Lastly, deprotection of the Boc group of (P)-3 with a mixture of TFA and CHCl 3 (2: 3 v/v), followed by similar coupling with (P)-6 gave first the expected FragmentA-B-C (P)-2, as shown in Scheme 6.
The structures of all the thus-obtained new products were confirmed by the spectral data (IH NMR , IR, and specific rotation) and satisfactory elemental analyses.
In conclusion, a useful synthetic method for the main central Fragment A-B-C skeleton of cyclothiazomycin (1) was successfully developed. A further investigation of the total synthesis of 1 is currently under way in our laboratory.
Experimental
The melting points were measured using a Yamato (Model Mp-21) micro-melting point apparatus, and are uncorrected. The IR spectra were recorded using an EPI-G2 spectrometer in KBr. The ramethylsilane used as the internal standard. The specific rotations were measured in a 0.5 dm tube using a JASCO DIP-4 polarimeter in MeOH. Thin-layer chromatography (TLC) was performed with Merck silica-gel 60Art 5554 plates, and column chromatography was carried out with Merck silica-gel 60 or Wakogel C-300. Starting Materials. H-Gly-OH, H-L-Ser-OH, and H-L-Thr-OH were purchased from Nippon Rikagakuyakuhin Co., Ltd.
(S}-3-t-Butoxycarbonyl-2,2-dimethyloxazolidine-4-thiocarboxamide (7) . A solution of (S)-3-t-butoxycarbonyl-2,2-dimethyloxazolidine-4-carboxamide 4 (1.51 g, 6.19 mmol) and Lawesson's reagent (1.38 g, 3.40 mmol) in DME (100 mL) was stirred at room temperature for 18 h. The reaction mixture was concentrated in vacuo to give a residual syrup, which was purified on a silica-gel column using a mixture of hexane and EtOAc (1:1 v/v) to give a solid material. Recrystallization from a hexane-EtOAc gave 7 as colorless prisms. Yield 80% (1.29 g). Mp 114-115 dc.
[alii +14.9°(c 1.01, MeOH). IR 3346, 3275, 3182, 3006, 2982 IR 3346, 3275, 3182, 3006, , 2943 IR 3346, 3275, 3182, 3006, ,2885 IR 3346, 3275, 3182, 3006, ,1479 IR 3346, 3275, 3182, 3006, ,1438 Ethyl (S)-2-(3-t-Butoxycarbonyl-2,2-dimethyloxazolidin-4-yl)thiazole-4-carboxylate (8) . To a solution of 7 (533 mg, 2.05 mmol) in DME (20 mL) in the presence ofKHC0 3 (410 mg, 4.10 mmol) was added, with stirring, BrCH 2 COCOOEt (0.51 mL, 4.10 (1.07 mL, 13.33 mmol) at 0 ec. The reaction mixture was stirred continuously for 1 h and then concentrated in vacuo to give a residual substance, which was dissolved in EtOAc (30 mL). The resuIting solution was washed successively with 10% citric acid (30 mL X 3), saturated NaHC0 3 aqueous solution (30 mL X 3), and brine (30 mL X 3) and then dried over anhydrous Na2S04. Concentration in vacuo gave a residue, which was purified on a silicagel column using a mixture of hexane and EtOAc (S)-2-(3-t-Butoxycarbonyl-2,2-dimethyloxazolidin-4-yl)thiazole-4-carboxylic Acid (9) . A solution of 8 (1.38 g, 3.87 mmol) and 1 M LiOH (5.81 mL) in a mixture of water and dioxane (50 rnL, 1: 1 v/v) was stirred at 0°C. After stirring for 30 min and at room temperature for 3 h, the reaction mixture was washed with diethyl ether (30 mL X 3). Th~aqueous layer was acidified with citric acid hydrate to pH 4 and then extracted with EtOAc (30 rnL X 3). The combined extracts were washed with brine (30 mL X 3) and dried over anhydrous Na2S04. Concentration in vacuo gave crude crystals, which were recrystallized from a hexaneEtOAc to give 9 as colorless crystals. Yield 97% (1.26 g). Mp 230-232 0c. [a] (S)-2-(3-t-Butoxycarbonyl-2,2-dimethyloxazolidin-4-yl)thiazole-4-carboxamide (10) . A solution of 9 (1.27 g, 3.87 mmol) and ethyl chloroformate (0.41 mL, 4.26 mmol) in THF (30 mL) in the presence of Et3N (0.59 rnL, 4.26 mmol) was strried at 0°C for 30 min. To the resulting solution was added 28% aq NH 3 (0.42 rnL, 5.81 mmol) and, after stirring for 5 min, the aqueous layer was removed. The organic layer was dried over anhydrous Na2S04 and concentrated in vacuo to give crude crystals. Recrystallization from a hexane-EtOAc gave 10 as colorless crystals. Yield 99% (1.26 g). Mp 157-159°C. [a] (S)-2-(3-t-Butoxycarbonyl-2,2-dimethyloxazolidin-4-yl)thiazole-4-thiocarboxamide (11) . A solution of 10 (1.26 g, 3.85 mmol) and Lawesson's reagent (856 mg, 2.12 mmol) in DME (30 rnL) was stirred at room temperature for 10 h. The reaction mixture was concentrated in vacuo to give a residual substance, which was purified on a silica-gel column using a mixture of hexane and EtOAc (l: 1 vIv) to give yellow crystals. Recrystallization from a hexane-EtOAc. gave 11 as yellow prisms. Yield 70% (924 mg). Mp 178-179°C. [a] Bull. Chern. Soc. Jpn., 75, No.7 (2002) 1589 mmol) in the presence of KHC0 3 (472 mg, 4.72 mmol) in DME (30 rnL) were stirred at 0°C for 2 h. To the resulting solution was added, with stirring, TFAA (0.98 mL, 7.08 mmol) and pyridine (1.23 mL, 15.34 mmol) and, after stirring for 1 h, the reaction mixture was concentrated in vacuo to give a residual substance. The residue was dissolved in EtOAc (30 mL) and the resultant solution was washed successively with 10% citric acid (30 mL X 3), saturated NaHC0 3 aqueous solution (30 mL X 3), and brine (30 mL X 3), and then dried over anhydrous Na2S04. Concentration in vacuo gave crude crystals, which were purified on a silica-gel column using a mixture of hexane and EtOAc (2: 1 vIv) to give 12 as colorless crystals. Yield 98% (1.03 g). Mp 134-136 0c. [a] (S)-2-[2-(3-t-Butoxycarbonyl-2,2-dimethyloxazolidin-4-yl)-thiazol-4-yl]thiazole-4-carboxylic Acid (13) . A solution of 12 (1.01 g, 2.30 mmol) and 1 M LiOH (3.45 mL) in a mixture of H 2 0 and dioxane (30 mL, 1: 1 v/v) was stirred at 0°C for 30 min and then at room temperature for 3 h. After washing with diethyl ether (30 rnL X 3), the aqueous layer was acidified to pH 4 with citric acid hydrate. The reaction mixture was extracted with EtOAc (30 mL X 3) and the combined extracts were washed with brine (30 mL X 3) and then dried over anhydrous Na2S04. Concentration in vacuo gave crude crystals, which were recrystallized from a hexane-EtOAc to give 13 as colorless needles. Yield 98% (945 mg). ( (14) . To a solution of 13 (392 mg, 0.95 mmol) and H-Ser(TBS)-OMe (357 mg, 1.53 mmol) in the presence of Et3N (0.24 mL, 1.71 mmol) in DMF (20 rnL) was added, with stirring, DPPA (0.27 mL, 1.24 mmol) at 0 0c. The resulting solution was stirred for 30 min and continuously at room temperature for 9 h and then extracted with EtOAc (30 rnL X 3). The combined extracts were washed with 10% citric acid (30 mL X 3), saturated NaHC0 3 aqueous solution (30 mL X 3), and brine (30 mL X 3) and then dried over anhydrous Na2S04. Concentration in vacuo gave a residual syrup, which was purified on a silica-gel column using a mixture of hexane and EtOAc (2: 1 v/v) to give 14 as a pale-yellow syrup. Yield 98% (595 mg). [a] (
S,R)-2-[2-(3-t-Butoxycarbonyl-2,2-dimethyloxazolidin-4-yl)-thiazol-4-yl]thiazole-4-carbonyl-L-Ser(TBS)-OMe

S,R)-2-[2-(3-t-Butoxycarbonyl-2,2-dimethyloxazolidin-4-y1)-thiazol-4-yl]thiazole-4-thiocarbonyl-L-Ser-OMe (16).
A solution of 15 (486 mg, 0.76 mmol) and TBAF (1.13 mL, 1 M in THF) in THF (10 mL) was stirred at 0°C for 1 h. Evaporation of THF gave a residual substance, which was purified on a silica-gel column using a mixture of hexane and EtOAc (1: 1 vIv) to give 16 as a yellow amorphous material. Yield 66% (264 mg). [a] (17) . To a solution of 16 (249 mg, 0.47 mmol) in THF (10 mL) were added, with stirring, Ph 3 P (185 mg, 0.71 mmol) and DEAD (40% in toluene; 0.28 mL, 0.71 mmol) at 0 0C. After stirring for 1 h, evaporation of THF gave a residual substance, which was purified on a silica-gel column using a mixture of hexane and EtOAc (1:1 v/v) to give 17 as a colorless amorphous material. Yield 72% (173 mg). [a] (10 mL, 4:96 v/v) was stirred at room temperature for 2 h. The reaction mixture was neutralized with saturated NaHC0 3 aqueous solution and the organic layer was washed with brine (10 mL X 3) and dried over anhydrous Na2S04. Concentration in vacuo gave a residual substance, which was purified on a silica-gel column using a mixture of hexane and EtOAc (1:1 v/v) to give 18 as colorless crystals. Yield 70% (112 mg). Mp 207-209°C. [a] 4-yl}-4,5-dihydrothiazole-4-carboxyiate (19) . To a solution of 18 (100 mg, 0.21 mmol) in CHCh (5 mL) were added, with stirring, TPS-Cl (6 ilL, 0.25 mmol) and imidazole (29 mg, 0.42 mmol) at 0 0C. After stirring for 12 h, the reaction mixture was washed with brine (5 mL X 3) and dried over anhydrous Na2S04. Concentration in vacuo gave a residual syrup, which was purified on a silica-gel column using a mixture of hexane and EtOAc (3: 1 v/v) to give 19 as a colorless syrup. Yield 97% (145 mg). [a] Methyl 6-Dimethoxymethyl-2-oxo-l,2-dihydr.opyridine-3-carboxylate (22). A solution of 20 (10.0 g, 51.5 mmol) and 6 M KOH (100 mL) in EtOH (100 mL) was refluxed for 8 h. Evaporation of EtOH gave an aqueous reaction mixture, which was washed with diethyl ether (30 mL X 3). The aqueous layer was acidified to pH 4 with citric acid hydrate and the resulting solution was extracted with EtOAc (100 mL X 5). The combined extracts were washed with brine (50 mL) and dried over anhydrous Na2S04. Concentration in vacuo gave a residual substance 21, which was dissolved in MeOH (200 mL). To the resulting solution was added p-toluenesulfonic acid hydrate (4.43 g) and, after refluxing overnight, the resultant solution was neutralized with Et3N at room temperature. Concentration in vacuo gave crude crystals, which were purified on a silica gel column using a mixture of CHCh and acetone (7 : 1 vIv) to give colorless crystals. Recrystallization from a hexane-EtOAc gave 22 as colorless needles. Yield 63% (7.73 Methyl 6-Dimethoxymethyl-2-triftuoromethylsulfonyloxypyridine-3-carboxylate (23). To a solution of 22 (2.0 g, 8.80 mmol) in pyridine (50 mL) were added, with stirring, DMAP (1.51 g, 12.32 mmol) and Tf 2 0 (1.59 g, 9.68 mmol) at 0 0C. After stirring for 30 min, the reaction mixture was concentrated in vacuo to give a residual substance, which was dissolved in EtOAc (70 mL). The resulting solution was washed with a saturated NaHC0 3 aqueous solution (10 mL X 3), and brine (10 mL X 3) and then dried over anhydrous Na2S04. Concentration in vacuo gave a syrup, which was purified on a silica-gel column using a mixture of hexane and EtOAc (1:1 v/v) to give 23 as a colorless syrup. Yield 81% (2.56 g). IR 3478, 2932 IR 3478, , 2836 IR 3478, , 2248 IR 3478, ,1725 IR 3478, ,1608 IR 3478, ,1557 = 7.8 Hz) . Found: C, 36.65; H, 3.39; N, 3.84%. Calcd for CIIHI2N07SF3: C, 36.77; H, 3.37; N, 3.90%.
Methyl (S,R)-2-{2-[2-(3-t-Butoxycarbonyl-2,2-dimethyloxazolidin-4-yl)thiazol-4-yl]thiazol-4-yl}-4,5-dihydrothiazole-4-carboxylate
11.91%. Methyl (S,R)-2-{2-[2-(I-t-Butoxycarbonylamino-2-t-butyldiphenylsiloxyethyl)thiazol-4-yl]thiazol-
Methyl 6-Dimethoxymethyl-2-(I-ethoxyethenyl)pyridine-3-carboxylate (24). To a solution of 23 (2.64 g, 7.35 mmol) in toluene (50 mL) were added Pd(OAch (0.25 g, 1.11 mmol), dppp (0.45 g, 1.09 mmol), ethyl vinyl ether (8.49 mL, 88 .30 mmol) and
Et3N (3.08 mL, 22.10 mmol) at room temperature. The resulting suspension was refluxed for 6 h and then concentrated in vacuo to give a residual substance, which was dissolved in CHCh (70 mL). The obtained solution was washed with brine (30 mL X 2) and dried over anhydrous Na2S04. Concentration in vacuo gave a residual syrup, which was purified on a silica-gel column using a mixture of hexane and EtOAc (1: 1 v/v) to give 24 as a colorless syrup. Without purification, the compound 24 was used to the next reaction.
Methyl 2-Acetyl-6-dimethoxymethylpyridine-3-carboxylate (25). To a solution of 24 (1.43 g, 5.08 mmol) in THF (5 mL) was added, with stirring, 70% AcOH (50 mL) at room temperature. After stirring overnight, the reaction mixture was concentrated in vacuo to give a residual syrup, which was purified on a silica-gel column using a mixture of hexane and EtOAc (1:1 v/v) to give 25 as a pale-yellow syrup. Yield 91 % (1.28 g) 
(RS)-2-(1-Hydroxyethyl)-3-hydroxymethyl-6-dimethoxyme-
thylpyridine (26). To a solution of 25 (2.58 g, 10.20 mmol) in EtOH (50 rnL) were added, with stirring, CaCh (6.80 g, 61.27 mmol) and NaBHt (2.32 g, 61.33 mmol) at 0 DC. After stirring for 30 min and for 3 h at room temperature, a saturated NH 4 Cl aqueous solution (50 mL) was added to the reaction mixture. Evaporation in vacuo gave a residual aqueous layer. The layer was extracted with EtOAc (50 mL X 5) and the combined extracts were dried over anhydrous Na2S04. Concentration in vacuo gave a syrup, which was purified on a silica-gel column using EtOAc to give 26 as a colorless syrup. Yield 94% (2.17 g N0 4 : C, 58.14; H, 7.54; N, 6.16%. (RS)-3-t-Butyldiphenylsiloxymethyl-6-dimethoxymethyl-2-(l-hydroxyethyl)pyridine (27). To a solution of 26 (0.31 g, 1.36 mmol) in CH 2 Ch (30 mL) were added, with stirring, Et3N (0.23 mL, 1.64 mmol), DMAP (0.02 g, 0.16 rnmol), and TPS-Cl (0.36 rnL, 1.55 mmol) at 0 DC for 30 min. After stirring at room temperature for 2 h, diethyl ether (40 mL) was added to the reaction mixture. The resulting solution was washed successively with 10% citric acid (30 mL X 3), a saturated NaHC0 3 aqueous solution (30 mL X 3), and brine (30 mL X 3) and then dried over anhydrous Na2S04. Concentration in vacuo gave a residual syrup, which was purified on a silica-gel column using a mixture of hexane and EtOAc (1: 1 v/v) to give 27 as a colorless syrup. Yield 86% (0.54 g). IR 3448,2854 IR 3448, ,2230 IR 3448, ,1959 IR 3448, ,1893 IR 3448, ,1821 IR 3448, ,1728 Bull. Chern. Soc. Jpn., 75, No.7 (2002) 1591 mL, 1.29 mmol) and Ms-CI (0.10 mL, 1.23 mmol) at 0 DC. After stirring for 10 min, the reaction mixture was mixed with diethyl ether (60 mL) and the resulting solution was washed with brine (30 mL), and then dried over anhydrous Na2S04. Concentration in vacuo gave a residual substance, which was purified on a silicagel column using a mixture of hexane and EtOAc (3: 1 v/v) to give a colorless syrup. The obtained syrup was again dissolved in DMF (40 mL) and the resulting solution was stirred with NaN 3 (0.31 g, 4.71 mmol) at room temperature for 30 min. The reaction mixture was extracted with EtOAc (30 mL X 3) and the combined extracts were washed with brine (30 mL) and then dried over anhydrous Na2S04. Concentration in vacuo gave a residual syrup, which was purified on a silica-gel column using a mixture of hexane and EtOAc (5: 1 v/v) to give 28 as a colorless syrup. Yield 92% (0.42 g). IR 3304,2902 IR 3304, ,2074 IR 3304, ,1902 IR 3304, ,1821 IR 3304, ,1737 IR 3304, ,1587 C, 65.68; H, 6.91; N, 11.60%. Calcd for C27H34N403Si: C, 66.04; H, 6.98; N, 11.42%. (RS)-2-(1-t-Butoxycarbonylaminoethyl)-3-t-butyldiphenylsiloxymethyl-6-dimethoxymethylpyridine (30). A suspension of 28 (1.0 g, 2.03 mmol) and 10% Pd-C (0.10 g) in EtOH (50 mL) was stirred under H 2 gas stream for 30 min at room temperature. After the Pd-C was filtered off, the filtrate was concentrated in vacuo and the residual substance 29, which was in situ dissolved in CHCh (50 mL). To the resulting solution were added, with stirring, Et3N (0.28 mL, 2.03 mmol) and Boc20 (0.53 g, 2.40 mmol) at 0 DC. After stirring for 30 min and at room temperature for 4 h, the reaction mixture was mixed with diethyl ether (70 mL), and then washed with 10% citric acid (30 mL X 2), saturated NaHC0 3 aqueous solution (30 mL X 2) and brine (30 mL X 2), and finally dried over anhydrous Na2S04. Concentration in vacuo gave a residual syrup, which was purified on a silica-gel column using a mixture of hexane and EtOAc (1:1 v/v) to give 30 as a colorless syrup. Yield 98% (1.14 g) from 28 in two steps. IR 3418, 2914 , 1707 , 1575 h), 3H, CHNH and CH 2 ), 5.36 (s, 1H, CH(CH 3 h), 6.05 (br d, 1H, NH, J = 7.3 Hz), (each m, llH, TPS's Ph X 2 and pyridine's H), 7.85 (d, 1H, pyridine's H, J = 8.1 Hz) . Found: C, 67.64; H, 8.05; N, 4.55%. Calcd for C32H~20sSi: C, 68.05; H, 7.85; N, 4.96%. Methyl (RS)-2-[2-(1-t-Butoxycarbonylaminoethyl)-3-(t-butyldiphenylsiloxymethyl)pyridin-6-yl]thiazole-4-carboxylate (32). After a solution of 30 (3.0 g, 5.31 rnmol) and 2 M HCI (40 mL) in THF (40 mL) was stirred at room temperature overnight, the reaction mixture was neutralized with saturated NaHC0 3 aqueous solution. After evaporating THF, the residue was extracted with EtOAc (50 mL X 3). The combined extracts were washed with saturated NaHC0 3 aqueous solution (50 mL X 3) and brine (50 mL X 2), and then dried over anhydrous Na2S04. Concentration in vacuo gave a residual substance 30, which was dissolved in toluene (80 mL). The resultant solution was stirred with H-L-CysOMe·HCI (1.82 g, 10.62 mmol) in the presence of Et3N (1.48 mL, 10.62 mmol) at 0 DC for 10 h. Concentration in vacuo gave a residual substance, which was dissolved again in EtOAc (l00 mL) and then washed with 10% citric acid (40 mL X 3), a saturated NaHC0 3 aqueous solution (40 mL X 3), brine (40 mL X 3) and then dried over anhydrous Na2S04. After concentrating in vacuo, the obtained residue was dissolved in toluene (80 mL); to the resulting solution was added Mn0 2 (9.23 g, 106.2 mmol), and the mixture was stirred at room temperature overnight. After removal of Mn0 2 , the reaction mixture was concentrated in vacuo to give a viscous syrup, which was purified on a silica-gel column using a mixture of hexane and EtOAc (3: 1 v/v) to give 32 as a colorless amorphous material. Yield 57% (1.91 g) C, 64.63; H, 6.54; N, 6 .65%.
(RS)-2-[2-(1-t-Butoxycarbonylaminoethyl)-3-(t-butyldiphenylsiloxymethyl)pyridin-6-yl]thiazole-4-carboxylic Acid (33). To a solution of 32 (6.20 g, 9. 81 mmol) in H 2 Q-dioxane (60 mL, 1:1 v/v) was added, with stirring, 1 M LiOH (11.77 mL, 11.77 mmol) at 0 0c. After stirring for 10 min and for 5 h at room temperature, the resultant solution was acidified with citric acid hydrate to pH 4. The reaction mixture was extracted with EtOAc (50 mL X 3) and the combined extracts were washed with brine (30 mL X 2), and then dried over anhydrous Na2S04. Concentration in vacuo gave a colorless syrup 33, which was intact used the next reaction.
Phenacyl 4-carboxylate (34) . To a solution of 33 (2.36 g, 3.82 mmol) in DMF (50 mL) were added, with stirring, Et3N (0.80 mL, 5.73 mmol) and Pac-Br (1.14 g, 5.37 mmol) at 0 0c. After stirring for 30 min and at room temeperature for 6 h, the reaction mixture was added to water (50 mL). The resulting solution was extracted with EtOAc (30 mL X 3) and the combined extracts were dried over anhydrous Na2S04. Concentration in vacuo gave a residual syrup, which was purified on a silica-gel column using a mixture of hexane and EtOAc (1:1 v/v) to give 34 as a colorless amorphous material. Yield 83% (2.45 g). IR 3435, 3070, 2960 IR 3435, 3070, , 2930 IR 3435, 3070, , 2891 IR 3435, 3070, , 2857 IR 3435, 3070, , 2359 IR 3435, 3070, , 1704 IR 3435, 3070, , 1586 Phenacyl (RS)-2-[2-(1-t-Butoxycarbonylaminoethyl)-3-(hydroxymethyl)pyridin-6-yl]thiazole-4-carboxylate (35). To a solution of 34 (1.0 g, 1.36 mmol) in TIIF (30 mL) was added, with stirring, TBAP (2.04 mL of 1 M TIIF, 2.04 mmol) at 0 0c. After stirring for 30 min, the reaction mixture was concentrated in vacuo to give a residual substance. The residue was purified on a silicagel column using a mixture of hexane and EtOAc (1: 1 v/v) to give colorless crystals, which were recrystallized from a hexaneEtOAc to give 35 as colorless crystals. Yield 77% (0.52 g). Mp 173-174°C. IR 3450, 3377, 3133, 2974 IR 3450, 3377, 3133, , 2930 IR 3450, 3377, 3133, , 2888 IR 3450, 3377, 3133, ,1734 IR 3450, 3377, 3133, ,1699 IR 3450, 3377, 3133, , 1663 IR 3450, 3377, 3133, ,1599 IR 3450, 3377, 3133, ,1583 IR 3450, 3377, 3133, ,1518 pyridin-5-yl)thiazole-4-carboxylate (36). To a solution of 35 (1.07 g, 2.15 mmol) in acetone (75 mL) was added 2.67 M Jones reagent (1.21 mL, 3.23 mmol) at 0 0C. After stirring for 40 min, the reaction mixture was mixed with i-PrOH (40 mL) and the precipitated Cr salt was filtered off. The filtrate was made to pH 9 with a saturated NaHC0 3 aqueous solution. Evaporation of acetone gave a residual solution, which was extracted with EtOAc (40 mL X 3); the combined extracts were washed with brine (30 mL X 3) and then dried over anhydrous Na2S04. Concentration in vacuo gave residual crystals, which were purified on a silica-gel column using a mixture of hexane and EtOAc (1:2 v/v) to give crude crystals. Recrystallization from a hexane-EtOAc gave 36 as a colorless amorphous material. Yield 83% (0.88 g). IR 3749, 3417, 2931 IR 3749, 3417, , 2360 IR 3749, 3417, , 1738 IR 3749, 3417, , 1596 (
RS)-Z-(lH-Z-t-Butoxycarbonyl-I-oxo-Z,3-dihydropyrrolo-[3,4-b]pyridin-5-yl)thiazole-4-carbonyl-L-Ser(TBS)-OBut (38).
A solution of 36 (0.52 g, 1.05 mmol) and K 2 C0 3 (0.44 g, 3.15 mmol) in water-TIIF (40 mL, 1:2 v/v) was stirred at 0°C for 30 min and then at room temperature for 8 h. Evaporation of THF gave an aqueous solution, which was acidified to pH 4 with citric acid hydrate. The reaction mixture was extracted with EtOAc (20 mL X 2) and the combined extracts were washed with brine (10 mL X 2) and then dried over anhydrous Na2S04. Concentration in vacuo gave a free acid 37 as a residual substance, which was in situ dissolved in DMF (30 mL). To the resulting solution were added, with stirring, H-L-Ser(TBS)-OBu t (0.32 g, 1.16 mmol), Et3N (0.23 mL, 1.68 mmol), and DPPA (0.30 mL, 1.37 mmol) at 0 0C. After stirring for 30 min and at room temperature overnight, water (30 mL) was added to the reaction mixture, and the resulting solution was extracted with EtOAc (20 mL X 3). Tqe combined extracts were washed with 10% citric acid (20 mL X 2), saturated NaHC0 3 aqueous solution (20 mL X 2), and brine (20 mL X 2) and then dried over anhydrous Na2S04. Concentration in vacuo gave a residue, which was purified on a silica-gel column using a mixture of CHCh and acetone (1:1 v/v) to give 38 as a colorless amorphous material. Yield 70% (0.47 g). IR 3418, 2932 IR 3418, , 2857 IR 3418, , 1783 IR 3418, , 1748 IR 3418, , 1682 IR 3418, , 1594 IR 3418, , 1537 IR 3418, , 1506 Z-{3-Benzyloxycarbonyl-Z-[(lSR)-l-t-butoxycarbonylaminoethyl]pyridin-6-yl} thiazole-4-carbonyl-L-Ser(TBS)-OBut (40). A solution of 38 (2.59 g, 4.09 mmol) and 1 M LiOH (12.27 mL, 12. 27 mmol) in THF-water (100 mL, 2: 1 v/v) was stirred at 0°C for 30 min and at room temperature for 1 h. Evaporation of THF gave a residual aqueous solution, which was extracted with EtOAc (50 mL X 3). The combined extracts were dried over anhydrous Na2S04 and concentrated in vacuo to give a residue 39, which was in situ dissolved in DMF (50 mL). To the resulting solution were added, with stirring, Et3N (1.31 mL, 9.41 mmol) and Bn-Br (0.97 mL, 8.18 mmol) at 0 0c. After stirring for 30 min and at room temperature for 12 h, water (50 mL) was added to the reaction mixture and the resulting solution was extracted with EtOAc (30 mL X 3). The combined extracts were washed with 10% citric acid (30 mL X 3), saturated NaHC0 3 aqueous solution (30 mL X 3), and brine (30 mL X 3), and then dried over anhydrous Na2S04. Concentration in vacuo gave a residue, which was purified on a silica-gel column using a mixture of hexane and EtOAc (2: 1 v/v) to give 40 as a colorless amorphous material. Yield 67% (2.03 g) in two steps from 38. IR 3419, 2977 IR 3419, , 2931 IR 3419, , 2885 IR 3419, , 2857 IR 3419, , 1720 IR 3419, , 1677 IR 3419, , 1584 IR 3419, , 1536 (S)-2-(1-Hydroxyethyl)pyridine [(S)-49] . According to the method reported,14 the treatment of 2-acetylpyridine (2.50 g, 26.64 mmol) with dry Yeast (56 g) and D-glucose (64 g) in water (500 mL) at room temperature for 24 h gave (S)-49 as a colorless oil. Yield 48% (1.22 g). [a] f, EtOH) . {lit. 14 [a]D -55.5°(c 1.50, EtOH)}.
(R)-2-(1-Hydroxyethyl)pyridine [(R)-49] . A solution of (S)-49 (1.56 mg, 1.27 mmol) and Ms-CI (0.15 mL, 2.54 mmol) in the presence of Et3N (0.53 mL, 3.81 mmol) in CHCh (20 mL) was stirred at 0°C for 30 min. The reaction mixture was washed with brine (10 mL X 3), dried over anhydrous Na2S04, and then concentrated in vacuo to give a residue. The residue was dissolved in DMF (20 ml), to which was added AcONa (313 mg, 3.81 mmol) and 15-crown-5-ether (18 pL, 0.13 mmol) at room temperature. After stirring for 24 h, to the reaction mixture was added water (20 mL) and then the resulting solution was extracted with EtOAc (20 mL X 2). The combined extracts were washed with brine (20 mL X 3), dried over anhydrous Na2S04 and then concentrated in vacuo to give a residue. The obtained residue was purified on a silicagel column using a mixture of hexane and EtOAc (2: 1 v/v) to give a residual oil. The oil was again dissolved in a MeOH-water (20 mL, 2: 1 v/v), to which was added, with stirring, K 2 C0 3 (263 mg, 1.91 mmol) at 0°C for 30 min. After stirring for 3 h at room temperature, MeOH was evaporated and the residual aqueous layer was extracted with EtOAc (20 mL X 5). The combined extracts were washed once with brine (20 mL), dried over anhydrous Na2S04, and then concentrated in vacuo to give a residual oil. The obtained oil was purified on a silica gel column using EtOAc to give (R)-49 as a colorless oil. Yield 46% (72 mg). [a] f,4 + 56.2°(c 1.53, EtOH).
(R)-2-(1-Azidoethyl)pyridine [(R)-50] . A solution of (S)-49 (185 mg, 1.50 mmol) and Ms-CI (0.23 mL, 3.00 mmol) in the presence of Et3N (0.62 mL, 4.50 mmol) in CHCh (20 mL) was stirred at 0°C for 30 min. The reaction mixture was washed with brine (10 mL X 3), dried over anhydrous Na2S04 and then concentrated in vacuo to give a residual substance. The residue was dissolved in DMF (20 mL) and treated with NaN 3 (293 mg, 450 mmol) at room temperature. After stirring overnight, the reaction mixture was diluted with water (20 mL) and the resulting solution was extracted with EtOAc (20 mL X 2). The combined extracts were washed with brine (20 mL X 3) and dried over anhydrous Na2S04. Concentration in vacuo gave a residual oil, which was purified on a silica-gel column using a mixture of hexane and EtOAc (2: 1 v/v) to give (R)-50 as a colorless oil. Yield 75% (166 mg). [a] fi5 +61.1°(c 1.09, MeOH). IR 2981 IR , 2933 IR , 2110 IR ,1592 
